Latest Results From an Ongoing First-in-Human Phase 1a/B Study of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients With Relapsed/Refractory CLL and Other B-Cell Malignancies

Kim Linton; Graham P. Collins; Francesco Forconi; Nirav N. Shah; Karan Dixit; Talha Munir; Zulfa Omer; Dima El-Sharkawi; Jeanette Doorduijn; Alvaro Alencar; Pam McKay; John Riches; Mary Gleeson; David Lewis; Allison Winter; Sarah Injac; Ted Shih; Srinand Nandakumar; May Tan; Ganesh Cherala; Erin Meredith; Alexey Danilov

doi:10.1016/S2152-2650(24)00597-4

$Latest Results From an Ongoing First-in-Human Phase 1a/B Study of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients With Relapsed/Refractory CLL and Other B-Cell Malignancies$

Journal article

Peer reviewed

Latest Results From an Ongoing First-in-Human Phase 1a/B Study of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients With Relapsed/Refractory CLL and Other B-Cell Malignancies

Kim Linton, Graham P. Collins, Francesco Forconi, Nirav N. Shah, Karan Dixit, Talha Munir, Zulfa Omer, Dima El-Sharkawi, Jeanette Doorduijn, Alvaro Alencar, …

Clinical lymphoma, myeloma and leukemia, Vol.24, pp.S184-S184

2024-09

DOI: https://doi.org/10.1016/S2152-2650(24)00597-4

Appears in Miller School of Medicine - Latest Publications

Metrics

15 Record Views

Details

Title: Latest Results From an Ongoing First-in-Human Phase 1a/B Study of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients With Relapsed/Refractory CLL and Other B-Cell Malignancies
Creators: Kim Linton - Cancer Research UK Manchester Centre
Graham P. Collins - University of Oxford
Francesco Forconi - University Hospital Southampton NHS Foundation Trust
Nirav N. Shah - Medical College of Wisconsin
Karan Dixit - Feinberg School of Medicine, Northwestern University, Chicago, USA
Talha Munir - St. James's Hospital
Zulfa Omer - University of Cincinnati
Dima El-Sharkawi - Royal Marsden NHS Foundation Trust
Jeanette Doorduijn
Alvaro Alencar - Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
Pam McKay - Beatson West of Scotland Cancer Centre
John Riches - Queen Mary University of London
Mary Gleeson - Sarah Cannon Research Institute
David Lewis - Derriford Hospital
Allison Winter - Cleveland Clinic
Sarah Injac - Nurix
Ted Shih - Nurix
Srinand Nandakumar - Nurix
May Tan - Nurix
Ganesh Cherala - Nurix
Erin Meredith - Nurix
Alexey Danilov - City Of Hope National Medical Center
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.24, pp.S184-S184
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032092350002976